Chris MacDonald

Chris MacDonald

InvestorPlace Contributor

Chris MacDonald is an MBA (finance) graduate with extensive experience covering small-, mid- and large-cap companies in the U.S. and Canadian markets. Chris is interesting in uncovering long-term and deep-value opportunities for investors based on principles from the Graham-Buffett school of thought, and looks forward to bringing investors a unique fundamental-based perspective on opportunities available in today’s challenging investing environment.

His experience as a financial analyst in the past, coupled with his fervor for finding undervalued growth opportunities, contribute to his conservative, long-term investing perspective.

Recent Articles

I’d Stay Clear of ChargePoint Stock Until the EV Sector Shakes Out a Little More

By Chris MacDonald, InvestorPlace Contributor

Investors in ChargePoint stock have been disappointed of late, as a number of headwinds have hit high-growth stocks hard in recent weeks.

Why Buying Carnival Stock Could Be the Ultimate Reopening Play

By Chris MacDonald, InvestorPlace Contributor

Here's why CCL stock could turn out to be the pandemic turnaround story investors are looking for, as the economy returns to normal.

RGLS Stock: 7 Things to Know About Red-Hot Regulus Therapeutics

By Chris MacDonald, InvestorPlace Contributor

Investors seem to believe something may be cooking with RGLS stock right now, given the outsized move we've seen today on a lack of news.

SOS Stock: 7 Things for Investors to Know About SOS Amid the Fraud Allegations

By Chris MacDonald, InvestorPlace Contributor

SOS stock has been highly volatile this past month, as investors decide whether to side with investors or short-sellers on this stock.

SEEL Stock: Why Biotech Play Seelos Therapeutics Is Soaring Today

By Chris MacDonald, InvestorPlace Contributor

SEEL stock has received a massive vote of confidence from a BTIG analyst today who placed a $14 price target on this biotech stock.

CCIV Stock: The Lucid Motors EV News That Has Shares Soaring Today

By Chris MacDonald, InvestorPlace Contributor

Investors in SPAC CCIV stock are bullish today, amid risk-on sentiment in the market and little in the way of tangible news.

OCGN Stock: 3 Big Reasons Ocugen Is Rocketing Higher Today

By Chris MacDonald, InvestorPlace Contributor

Investors in OCGN stock have a number of catalysts to point to today as reasons to hold onto this outperforming stock.

AMC Is a Meme Stock to Be Avoided Right Now

By Chris MacDonald, InvestorPlace Contributor

AMC stock has been a lottery ticket winner for many retail investors, but the party is likely close to being over right now.

Thinking of Loading Up on Ethereum? Here’s What to Know Before You Do

By Chris MacDonald, InvestorPlace Contributor

With Ethereum more than doubling since the beginning of the year, many investors may be enticed to jump in - here's how to do so.

MDMP Stock: Why MDM Permian Is Soaring 200% Today

By Chris MacDonald, InvestorPlace Contributor

MDMP stock is surging today on some positive news around the company's initial drilling and exploration for a key property.

Load More